|
1
|
Jiang Z, Shao J, Yang T, Wang J, Jia L. Pharmaceutical development, composition and quantitative analysis of phthalocyanine as the photosensitizer for cancer photodynamic therapy. J Pharm Biomed Anal 2014; 87:98-104. [DOI: 10.1016/j.jpba.2013.05.014] [Citation(s) in RCA: 86] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2013] [Revised: 05/04/2013] [Accepted: 05/11/2013] [Indexed: 12/22/2022]
|
|
2
|
Hudson R, Boyle RW. Strategies for selective delivery of photodynamic sensitisers to biological targets. J PORPHYR PHTHALOCYA 2012. [DOI: 10.1142/s1088424604000325] [Citation(s) in RCA: 57] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Strategies for increasing the affinity of photodynamic sensitisers for specific tissues, cells and organisms are reviewed. Biological outcomes are evaluated and therapeutic potential assessed.
Collapse
Affiliation(s)
- Robert Hudson
- Photobiology & Photomedicine Group, Department of Chemistry, University of Hull, Cottingham Road, Hull, East Yorkshire HU6 7RX, United Kingdom
| | - Ross W. Boyle
- Photobiology & Photomedicine Group, Department of Chemistry, University of Hull, Cottingham Road, Hull, East Yorkshire HU6 7RX, United Kingdom
| |
Collapse
|
|
3
|
Ke MR, Yeung SL, Fong WP, Ng DKP, Lo PC. A Phthalocyanine-Peptide Conjugate with High In Vitro Photodynamic Activity and Enhanced In Vivo Tumor-Retention Property. Chemistry 2012; 18:4225-33. [DOI: 10.1002/chem.201103516] [Citation(s) in RCA: 54] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2011] [Indexed: 12/26/2022]
|
|
4
|
Lovell JF, Liu TWB, Chen J, Zheng G. Activatable photosensitizers for imaging and therapy. Chem Rev 2010; 110:2839-57. [PMID: 20104890 DOI: 10.1021/cr900236h] [Citation(s) in RCA: 1227] [Impact Index Per Article: 87.6] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- Jonathan F Lovell
- Institute of Biomaterials and Biomedical Engineering, Ontario Cancer Institute, University of Toronto, Ontario M5G 1L7, Canada
| | | | | | | |
Collapse
|
|
5
|
Ma X, Pan H, Yi J. Combination sonodynamic therapy with immunoadjuvant may be a promising new modality for cancer treatment. Med Hypotheses 2009; 72:418-20. [DOI: 10.1016/j.mehy.2008.10.024] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2008] [Revised: 09/23/2008] [Accepted: 10/02/2008] [Indexed: 11/26/2022]
|